2024
Single-cell profiling of surface glycosphingolipids opens a new dimension for deconvolution of breast cancer intratumoral heterogeneity and phenotypic plasticity
PROCHÁZKOVÁ, Jiřina; Radek FEDR; Barbora HRADILOVÁ; Barbora KVOKAČKOVÁ; Josef SLAVIK et al.Základní údaje
Originální název
Single-cell profiling of surface glycosphingolipids opens a new dimension for deconvolution of breast cancer intratumoral heterogeneity and phenotypic plasticity
Autoři
PROCHÁZKOVÁ, Jiřina ORCID; Radek FEDR; Barbora HRADILOVÁ; Barbora KVOKAČKOVÁ; Josef SLAVIK; Ondrej KOVAC; Miroslav MACHALA; Pavel FABIAN; Jiri NAVRATIL; Simona KRACALIKOVA; Monika LEVKOVA; Petra OVESNÁ ORCID; Jan BOUCHAL a Karel SOUČEK
Vydání
JOURNAL OF LIPID RESEARCH, AMSTERDAM, ELSEVIER, 2024, 0022-2275
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30204 Oncology
Stát vydavatele
Nizozemské království
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.100
Označené pro přenos do RIV
Ne
Organizační jednotka
Přírodovědecká fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
phenotypic plasticity; breast cancer glycosphingolipids; surface profiling; epithelial cells; stromal-like cells
Štítky
Změněno: 25. 12. 2025 18:10, Mgr. Jiřina Procházková, Ph.D.
Anotace
V originále
Glycosylated sphingolipids (GSLs) are a diverse group of cellular lipids typically reported as being rare in normal mammary tissue. In breast cancer (BCa), GSLs have emerged as noteworthy markers associated with breast cancer stem cells, mediators of phenotypic plasticity, and contributors to cancer cell chemoresistance. GSLs are potential surface markers that can uniquely characterize the heterogeneity of the tumor microenvironment, including cancer cell subpopulations and epithelial-mesenchymal plasticity (EMP). In this study, mass spectrometry analyses of the total sphingolipidome in breast epithelial cells and their mesenchymal counterparts revealed increased levels of Gb3 in epithelial cells and significantly elevated GD2 levels in the mesenchymal phenotype. To elucidate if GSL-related epitopes on BCa cell surfaces reflect EMP and cancer status, we developed and rigorously validated a 12-color spectral flow cytometry panel. This panel enables the simultaneous detection of native GSL epitopes (Gb3, SSEA1, SSEA3, SSEA4, and GD2), epithelial-mesenchymal transition markers (EpCAM, TROP2, and CD9), and lineage markers (CD45, CD31, and CD90) at the single-cell level. Next, the established panel was used for the analysis of BCa primary tumors and revealed surface heterogeneity in SSEA1, SSEA3, SSEA4, GD2, and Gb3, indicative of native epitope presence also on non-tumor cells. These findings further highlighted the phenotype- dependent alterations in GSL surface profiles, with differences between epithelial and stromal cells in the tumor. This study provides novel insights into BCa heterogeneity, shedding light on the potential of native GSL-related epitopes as markers for EMP and cancer status in fresh clinical samples. The developed
Návaznosti
| LX22NPO5102, projekt VaV |
|